Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

References for PMC Articles for PubMed (Select 21103412)

1.

Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis.

Guzman MG, Jaenisch T, Gaczkowski R, Ty Hang VT, Sekaran SD, Kroeger A, Vazquez S, Ruiz D, Martinez E, Mercado JC, Balmaseda A, Harris E, Dimano E, Leano PS, Yoksan S, Villegas E, Benduzu H, Villalobos I, Farrar J, Simmons CP.

PLoS Negl Trop Dis. 2010 Aug 31;4(8). pii: e811. doi: 10.1371/journal.pntd.0000811.

2.

Past, present, and future of Japanese encephalitis.

Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K.

Emerg Infect Dis. 2009 Jan;15(1):1-7. doi: 10.3201/eid1501.080311.

3.

Ecology and geographical expansion of Japanese encephalitis virus.

van den Hurk AF, Ritchie SA, Mackenzie JS.

Annu Rev Entomol. 2009;54:17-35. doi: 10.1146/annurev.ento.54.110807.090510. Review.

PMID:
19067628
4.

Japanese encephalitis vaccines--needs, flaws and achievements.

Tauber E, Dewasthaly S.

Biol Chem. 2008 May;389(5):547-50. Review.

PMID:
18953721
5.

The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central sarawak, malaysia, 1997-2005.

Ooi MH, Lewthwaite P, Lai BF, Mohan A, Clear D, Lim L, Krishnan S, Preston T, Chieng CH, Tio PH, Wong SC, Cardosa J, Solomon T.

Clin Infect Dis. 2008 Aug 15;47(4):458-68. doi: 10.1086/590008.

6.

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

Schuller E, Jilma B, Voicu V, Golor G, Kollaritsch H, Kaltenböck A, Klade C, Tauber E.

Vaccine. 2008 Aug 12;26(34):4382-6. doi: 10.1016/j.vaccine.2008.05.081. Epub 2008 Jun 17.

PMID:
18599165
7.

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.

Tauber E, Kollaritsch H, von Sonnenburg F, Lademann M, Jilma B, Firbas C, Jelinek T, Beckett C, Knobloch J, McBride WJ, Schuller E, Kaltenböck A, Sun W, Lyons A.

J Infect Dis. 2008 Aug 15;198(4):493-9. doi: 10.1086/590116. Erratum in: J Infect Dis. 2010 Apr 15;201(8):1278.

8.

A cohort study to assess the new WHO Japanese encephalitis surveillance standards.

Solomon T, Thao TT, Lewthwaite P, Ooi MH, Kneen R, Dung NM, White N.

Bull World Health Organ. 2008 Mar;86(3):178-86.

9.

Cross-reactive IgM responses in patients with dengue or Japanese encephalitis.

A-Nuegoonpipat A, Panthuyosri N, Anantapreecha S, Chanama S, Sa-Ngasang A, Sawanpanyalert P, Kurane I.

J Clin Virol. 2008 May;42(1):75-7. doi: 10.1016/j.jcv.2007.10.030. Epub 2008 Mar 4.

PMID:
18304870
10.

Current use and development of vaccines for Japanese encephalitis.

Beasley DW, Lewthwaite P, Solomon T.

Expert Opin Biol Ther. 2008 Jan;8(1):95-106. Review.

PMID:
18081539
11.

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial.

Tauber E, Kollaritsch H, Korinek M, Rendi-Wagner P, Jilma B, Firbas C, Schranz S, Jong E, Klingler A, Dewasthaly S, Klade CS.

Lancet. 2007 Dec 1;370(9602):1847-53.

PMID:
18061060
12.

Does antiviral therapy have a role in the control of Japanese encephalitis?

Gould EA, Solomon T, Mackenzie JS.

Antiviral Res. 2008 Apr;78(1):140-9. Epub 2007 Nov 8. Review.

PMID:
18053589
13.

Evaluation of three immunoglobulin M antibody capture enzyme-linked immunosorbent assays for diagnosis of Japanese encephalitis.

Jacobson JA, Hills SL, Winkler JL, Mammen M, Thaisomboonsuk B, Marfin AA, Gibbons RV.

Am J Trop Med Hyg. 2007 Jul;77(1):164-8.

14.

Japanese encephalitis for a reference to international travelers.

Oya A, Kurane I.

J Travel Med. 2007 Jul-Aug;14(4):259-68. Review.

PMID:
17617849
15.

Control of Japanese encephalitis--within our grasp?

Solomon T.

N Engl J Med. 2006 Aug 31;355(9):869-71. No abstract available.

PMID:
16943399
16.

Japanese encephalitis vaccines.

[No authors listed]

Wkly Epidemiol Rec. 2006 Aug 25;81(34/35):331-40. English, French. No abstract available.

17.

Japanese encephalitis vaccine for travelers: exploring the limits of risk.

Shlim DR, Solomon T.

Clin Infect Dis. 2002 Jul 15;35(2):183-8. Epub 2002 Jun 19. Review.

18.

Japanese encephalitis virus: ecology and epidemiology.

Endy TP, Nisalak A.

Curr Top Microbiol Immunol. 2002;267:11-48. Review. No abstract available.

PMID:
12082986
19.

Japanese encephalitis.

Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT.

J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):405-15. No abstract available.

20.

Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Japanese encephalitis infections.

Cuzzubbo AJ, Endy TP, Vaughn DW, Solomon T, Nisalak A, Kalayanarooj S, Dung NM, Warrilow D, Aaskov J, Devine PL.

J Clin Microbiol. 1999 Nov;37(11):3738-41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk